KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Other financing activities (2016 - 2025)

Edwards Lifesciences has reported Other financing activities over the past 17 years, most recently at -$3.1 million for Q4 2025.

  • Quarterly results put Other financing activities at -$3.1 million for Q4 2025, down 3200.0% from a year ago — trailing twelve months through Dec 2025 was -$3.8 million (down 22.58% YoY), and the annual figure for FY2025 was -$3.8 million, down 22.58%.
  • Other financing activities for Q4 2025 was -$3.1 million at Edwards Lifesciences, down from -$2.4 million in the prior quarter.
  • Over the last five years, Other financing activities for EW hit a ceiling of $7.2 million in Q2 2024 and a floor of -$10.2 million in Q3 2024.
  • Median Other financing activities over the past 5 years was -$100000.0 (2021), compared with a mean of -$647368.4.
  • Biggest five-year swings in Other financing activities: soared 1900.0% in 2023 and later crashed 3200.0% in 2025.
  • Edwards Lifesciences' Other financing activities stood at $700000.0 in 2021, then crashed by 85.71% to $100000.0 in 2022, then soared by 1900.0% to $2.0 million in 2023, then plummeted by 95.0% to $100000.0 in 2024, then crashed by 3200.0% to -$3.1 million in 2025.
  • The last three reported values for Other financing activities were -$3.1 million (Q4 2025), -$2.4 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.